Frederick Funke, MD
Cardiovascular Disease · Ladson, SCNPI 1437357274
Payments from drug & device makers
Across 538 payments — averaging $266.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$133K
- Abbott$2K
- Boston Scientific$1K
- Medtronic$930
- E.r. Squibb & Sons, L.L.C.$683
- AstraZeneca$663
- plus $5K from 33 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 31 | $133,028 |
| Abbott | 78 | $1,679 |
| Boston Scientific | 48 | $1,145 |
| Medtronic(2 entities) | 50 | $930 |
| E.r. Squibb & Sons, L.L.C. | 47 | $683 |
| AstraZeneca | 44 | $663 |
| Inari Medical, Inc. | 2 | $534 |
| Boehringer Ingelheim | 25 | $465 |
| Cardiva Medical, Inc. | 30 | $461 |
| Philips North America LLC | 12 | $449 |
| Amgen | 28 | $352 |
| Johnson & Johnson | 25 | $351 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 19 | $312 |
| Pfizer | 17 | $283 |
| Merck | 11 | $164 |
| Abiomed | 1 | $143 |
| Livanova USA, Inc. | 1 | $133 |
| Endologix LLC | 2 | $122 |
| Teleflex LLC | 4 | $117 |
| Astellas Pharma US Inc | 6 | $114 |
| Edwards Lifesciences | 5 | $113 |
| Biotronik Inc. | 6 | $102 |
| Alnylam Pharmaceuticals Inc. | 5 | $99 |
| Irhythm Technologies, Inc. | 3 | $90 |
| Regeneron Healthcare Solutions, Inc. | 6 | $87 |
| Kiniksa Pharmaceuticals, Ltd. | 4 | $78 |
| Sanofi-aventis U.S. LLC | 4 | $75 |
| Esperion Therapeutics, Inc. | 5 | $74 |
| Lexicon Pharmaceuticals, Inc. | 4 | $70 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $60 |
| Cvrx, Inc. | 3 | $52 |
| Scpharmaceuticals Inc. | 2 | $39 |
| Heartflow, Inc. | 1 | $36 |
| Atricure, Inc. | 1 | $23 |
| Shockwave Medical, Inc | 1 | $19 |
| Preventice Services, LLC | 1 | $18 |
| Bayer | 1 | $18 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
How this compares
$143,206 in reported general payments places this provider in the 90th percentile of 257 cardiovascular disease providers in South Carolina.
See all cardiovascular disease providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Ladson
- Sofy LandesLadson$28K
- Christopher McCartyLadson$13K
- Brent McLaurinAnderson$1.1M
- Robert BiedermanCharleston$801K
- James MerriamGreenville$728K
- Vipul ShahLancaster$488K
- Arthur EberlyGreenville$438K
- Gregory SanGreenville$429K
- Naresh MoriRock Hill$408K
- Priya KumarGreenwood$351K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.